Table 6

Risk ratios, 95% CIs and p values for all the features from the modified Poisson regression and Bayesian network models for death

	Modified poisson				Bayesian network
	Death risk ratio	Death lower CI	Death upper CI	Death p value	Death risk ratio	Death lower CI	Death upper CI	Death p value
Moderate activity versus low activity	0.79	0.69	0.91	<0.001	0.69	0.60	0.80	<0.001
High activity versus low activity	0.58	0.50	0.68	<0.001	0.43	0.37	0.50	<0.001
35–49 vs below 35	4.34	3.03	6.22	<0.001	4.32	3.19	5.86	<0.001
50–59 vs below 35	7.58	5.25	10.94	<0.001	10.38	7.66	14.06	<0.001
60+ vs below 35	11.37	7.80	16.56	<0.001	27.45	20.35	37.03	<0.001
Males versus females	2.52	2.16	2.93	<0.001	2.46	2.14	2.82	<0.001
RUB 1 vs RUB 0	3.47	1.18	10.22	0.012	2.48	0.98	6.26	0.054
RUB 2 vs RUB 0	5.38	1.95	14.83	<0.001	4.50	1.92	10.54	<0.001
RUB 3 vs RUB 0	7.48	2.79	20.08	<0.001	6.61	2.90	15.04	<0.001
RUB 4 vs RUB 0	31.69	11.76	85.40	<0.001	28.57	12.53	65.16	<0.001
RUB 5 vs RUB 0	98.43	36.51	265.32	<0.001	107.35	47.18	244.30	<0.001
Oncology	1.03	0.85	1.25	0.393	2.33	1.77	3.06	<0.001
Hypercholesterolaemia	0.80	0.69	0.94	0.002
Angina syndrome	1.09	0.27	4.48	0.454
Congestive cardiac failure	1.18	0.84	1.65	0.183
Cardiomyopathy	0.75	0.38	1.47	0.199
Essential hypertension	1.27	1.11	1.46	<0.001	1.37	1.16	1.61	<0.001
Diabetes mellitus	1.61	1.37	1.89	<0.001	3.00	2.49	3.61	<0.001
Hypothyroidism	0.90	0.67	1.22	0.246
Crohns disease	0.30	0.04	2.13	0.110
Ulcerative colitis	0.67	0.32	1.39	0.138
HIV	1.67	1.19	2.34	0.002	1.04	0.64	1.69	0.866
Systemic lupus erythematosus	1.68	0.82	3.43	0.080
Rheumatoid arthritis	1.74	1.29	2.35	<0.001	2.11	1.35	3.29	0.001
Chronic renal failure	1.21	0.82	1.79	0.164	2.04	0.85	4.9	0.113
Epilepsy	1.02	0.70	1.49	0.416
Asthma	0.89	0.72	1.10	0.169
Conduction disorder	0.81	0.59	1.11	0.109
Multiple sclerosis	0.59	0.20	1.72	0.164
Bronchiectasis	1.75	0.77	4.00	0.097

RUB, resource utilisation band.